Picard Medical, Inc. - Asset Resilience Ratio
Picard Medical, Inc. (PMI) has an Asset Resilience Ratio of 20.80% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how Picard Medical, Inc.'s Asset Resilience Ratio has changed over time. Check strategic asset allocation of Picard Medical, Inc. to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Picard Medical, Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Picard Medical, Inc..
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $2.81 Million | 20.8% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $2.81 Million | 20.80% |
Asset Resilience Insights
- Good Liquidity Position: Picard Medical, Inc. maintains a healthy 20.80% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Picard Medical, Inc. Industry Peers by Asset Resilience Ratio
Compare Picard Medical, Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW |
Medical Devices | 9.20% |
|
DexCom Inc
NASDAQ:DXCM |
Medical Devices | 19.55% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Corentec Co Ltd
KQ:104540 |
Medical Devices | 2.80% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Annual Asset Resilience Ratio for Picard Medical, Inc. (2022–2024)
The table below shows the annual Asset Resilience Ratio data for Picard Medical, Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.79% | $96.00K | $12.11 Million | -1.35pp |
| 2023-12-31 | 2.15% | $244.00K | $11.37 Million | +1.16pp |
| 2022-12-31 | 0.98% | $152.00K | $15.44 Million | -- |
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internatio… Read more